Single-cell transcriptomic profiling enables the unprecedented interrogation of gene 18 expression heterogeneity in rare cell populations that would otherwise be obscured in 19
advantage of this unique characteristic. We present a new methodology to analyze 23 single-cell transcriptomic data that models this bimodality within a coherent generalized 24 linear modeling framework. We propose a two-part, generalized linear model that allows 25 one to characterize biological changes in the proportions of cells that are expressing 26 each gene, and in the positive mean expression level of that gene. We introduce the 27 cellular detection rate, the fraction of genes turned on in a cell, and show how it can be 28 used to simultaneously adjust for technical variation and so-called "extrinsic noise" at the 29 single-cell level without the use of control genes. Our model permits direct inference on 30 statistics formed by collections of genes, facilitating gene set enrichment analysis. The 31 residuals defined by such models can be manipulated to interrogate cellular 32 heterogeneity and gene-gene correlation across cells and conditions, providing insights 33 into the temporal evolution of networks of co-expressed genes at the single-cell level. 34
Using two single-cell RNA-seq datasets, including newly generated data from Mucosal 35
Associated Invariant T (MAIT) cells, we show how model residuals can be used to 36 identify significant changes across biologically relevant gene sets that are missed by 37 other methods and characterize cellular heterogeneity in response to stimulation. 38 39
Introduction: 40 Whole transcriptome expression profiling of single cells via RNA-seq (scRNA-seq) is the logical 41 apex to single cell gene expression experiments. In contrast to transcriptomic experiments on 42 mRNA derived from bulk samples, this technology provides powerful multi-parametric 43 measurements of gene co-expression at the single-cell level. However, the development of 44 equally potent analytic tools has trailed the rapid advances in the biochemistry and molecular 45 biology, and several challenges need to be addressed to fully leverage the information in single-46 cell expression profiles. 47 48 First, single-cell expression has repeatedly been shown to exhibit a characteristic bimodal 49 expression pattern, wherein the expression of otherwise abundant genes is either strongly 50 positive, or undetected within individual cells. This is due in part to low starting quantities of 51
RNA such that many genes will be below the threshold of detection, but there is also a biological 52 component to this variation (termed extrinsic noise in the literature) that is conflated with the 53 technical variability 1-3 . We and other groups 4-6 have shown that the proportion of cells with 54 detectable expression reflects both technical and biological differences between samples. 55 Results from synthetic biology also support the notion that bimodality can arise from the 56 stochastic nature of gene expression 2,3,7,8 . 57 58
Secondly, measuring single cell gene expression might seem to obviate the need to normalize 59 for starting RNA quantities. Recent work shows that cells scale transcript copy number with cell 60 volume (a factor that affects gene expression globally) to maintain a constant mRNA 61 concentration and thus constant biochemical reaction rates 9,10 . In scRNA-seq, cells of varying 62 volume are diluted to an approximately fixed reaction volume leading to differences in detection 63
rates of various mRNA species that are driven by the initial cell volumes. Technical assay 64 variability (e.g. mRNA quality, pre-amplification efficiency) and extrinsic biological factors (e.g. 65 nuisance biological variability due to cell size) remain, and can significantly influence expression 66 level measurements. Consequently, this may render traditional normalization strategies using 67 the expression level of a few "housekeeping" genes, like GAPDH, infeasible 10 . Recently, Shalek 68 et al 5 observed a strong relationship between average expression and detection efficiency, and 69
have proposed a computational approach to correct the estimated gene-specific probability of 70 detection. Our approach easily allows for estimation and control of the CDR simultaneously 71 while estimating treatment effects as opposed to previous approaches 5 that relied on a set of 72 control genes and could not jointly model both factors. 73 74 Previously, Kharchenko et al 6 developed a so-called three-component mixture model to test for 75 differential gene expression while accounting for bimodal expression. Their approach is limited 76 to two-class comparisons and cannot adjust for important biological covariates such as multiple 77 treatment groups and technical factors such as batch or time information, severely limiting its 78 utility in more complex experimental designs. On the other hand, several methods have been 79
proposed for modeling bulk RNA-seq data that permit complex modeling through linear 11 or 80 generalized linear models 12,13 but these models have not yet been adapted to single-cell data as 81 they do not properly account for the observed bimodality in expression levels. This is particularly 82 important when adjusting for covariates that might affect the expression rates. As we will 83
demonstrate later, such model mis-specification can significantly affect sensitivity and specificity 84 when detecting differentially expressed genes and gene-sets. 85 86
Here, we propose a Hurdle model tailored to the analysis of scRNA-seq data, providing a 87 mechanism to address the challenges noted above. It is a two-part generalized linear model that 88 simultaneously models the rate of expression over background of various transcripts, and the 89 positive expression mean. Leveraging the established theory for generalized linear modeling 90 allows us to accommodate complex experimental designs while controlling for covariates 91 (including technical factors) in both the discrete and continuous parts of the model. We 92 introduce the cellular detection rate (CDR): the fraction of genes that are turned on / detected in 93 each cell, which, as discussed above, acts as a proxy for both technical (e.g. dropout, 94 amplification efficiency, etc.) and biological factors (e.g. cell volume and other extrinsic factors 95 other than treatment of interest) that can influence gene expression. As a result it represents an 96 important source of variability in scRNA-seq data that needs to be considered ( Figure 1 ). Our 97 approach of modeling the CDR as a covariate, offers an alternative to the weight correction of 98
Shalek et al 5 that does not depend on the use of control genes and allows us to jointly estimate 99 nuisance and treatment effects. Our framework permits the analysis of complex experiments, 100
such as repeated single cell measurements under various treatments and/or longitudinal 101 sampling of single cells from multiple subjects with a variety of background characteristics (e.g. 102 gender, age, etc.) as it is easily extended to accommodate random effects. Differences between treatment groups than across groups, suggesting that it is likely to be a nuisance factor. This is 134 further supported by the fact that the CDR calculated within control (e.g. housekeeping) genes 135 is highly correlated with the CDR calculated over all genes ( Supplementary Figure 1 ). Its role as 136 a principal source of variation persists across experiments ( Figure 1 ). 137 138 We thus conjecture that CDR is a proxy for unobserved nuisance factors that should be 139 explicitly modeled. In particular, it is not unreasonable to suggest that the CDR captures 140 variation in global transcription rate due to variations in cell size (among other factors) 10 , as well 141
as technical variation such as dropout, with dropout rates possibly correlated with cell-size. 142
Fortunately, MAST easily accommodates covariates, such as the CDR, and more importantly 143 allows joint, additive modeling of them with other biological variables of interest, with the effect 144 of each covariate decomposed into its discrete and continuous parts. This two-part modeling is 145 key to account for the CDR that directly reflects the gene-level transcription rates. Applying an 146 analysis of deviance with MAST (see Methods), we quantified the amount of variability that 147 could be attributed to CDR. The CDR accounts for 5.2% of the deviance in the MAIT data set 148 and 4.8% in the mDC data set for the average gene, and often times much more than that: it 149 comprises more than 9% of the deviance in over 10% of genes in both data sets, particularly for 150 the discrete component of the model (Supplementary Figure 2 ). It should also be noted that the 151 CDR deviance estimates for many of the genes are comparable (if not greater) to the treatment 152 deviance estimates showing that it. 153 154
That CDR predicts expression levels contradicts the model of independent expression between 155 genes, since the level of expression (averaged across many genes) would not affect the level in 156 any given gene were expression independent. This pervasiveness suggests latent factors are 157 creating coordinated changes in expression across genes. In light of the work of Padovan-158
Merhar et al 10 , we conjecture the latent factor relates to differences in cell volumes, since cells 159 of different volumes compensate to conserve mRNA species molarity, which implies higher copy 160 numbers of all transcripts in larger cells. Higher copy numbers result in higher scRNA-seq 161 detection rates globally across transcripts. 162 163
Finally, we have investigated the relationship between our approach and the weight correction 164 of Shalek et al 5 ( Supplementary Figure 3 ). We observe a strong linear relationship between the 165 CDR and the weights of Shalek et al 5 . Thus, use of the CDR as a covariate can be seen as a 166 statistically rigorous way to correct for the dropout biases of Shalek et al 5 , without the need to 167 use control genes,, and more importantly with the ability to control for these while estimating 168 treatment effects. 169 170
Single-cell sequencing identifies a transcriptional profile of MAIT cell activation 171
We applied MAST to our MAIT dataset to identify genes up-or down-regulated by cytokine 172 stimulation while accounting for variation in the CDR (see Methods). We detected 291 173 differentially expressed genes, as opposed to 1413 when excluding CDR. To determine whether 174
this was due to a change in ranking or a simply a shift in significance, we compared the overlap 175 between the top ݊ genes in both models (varying ݊ from 100 to 1413), and found that, on 176 average, 35% (range 32% -38%) of genes are excluded when CDR is modeled, suggesting that 177 inclusion of this variable allows global changes in expression, manifest in the CDR, to be 178 decomposed from local changes in expression. This is supported by gene ontology enrichment 179 analysis (Supplementary Figure 4 ) of these CDR-specific genes (n=539), where we see no 180 enrichment for modules associated with treatment of interest. 181 182
In order to assess the type-I error rate of our approach, we also applied MAST to identify 183 differentially expressed genes across random splits of the non-stimulated MAIT cells. As 184 expected, MAST did not detect any significant differences (Supplementary Figure 5A ), whereas 185
DEseq and edgeR, designed for bulk RNA-seq, detected large number of differentially 186 expressed genes even at very low FDR thresholds. We examined the GO enrichment of genes 187 detected by limma or edgeR or DESeq but not MAST and found that these sets lacked 188 significant enrichment for modules related to the treatment of interest (Supplementary Figures  189 5B and 6-8). MAST's testing framework evidently has better specificity than these approaches. 190 191 Figure 2A shows We used these lists of up-and down-regulated genes to define a MAIT activation score that 202 differentiates between stimulated and non-stimulated MAITs as shown in Figure 2B . This score 203 (see Methods), for each cell, is defined as the expected expression level across genes in a 204 module (based on the model fit) corrected for nuisance factors (such as CDR, see Methods). 205
The score enables us to cleanly differentiate stimulated and non-stimulated cells, and 206 demonstrates that the stimulated MAIT population is much more heterogeneous in its 207 expression phenotype. In particular, a few stimulated MAIT cells (SC08, SC54, SC48, SC15, 208 SC46, and SC61 in Figure 2A ) exhibit low expression of IFNെߛ response genes, suggesting 209 these cells did not fully activate despite stimulation. Post-sort experiments via FCM show that 210 the sorted populations were over 99% pure MAITs (Supplementary Figure 9A ), and exhibited a 211 change in cell size upon stimulation (Supplementary Figure 9B ), and that up to 26% of 212 stimulated MAITs didn't express IFN-ߛ or GZMB following cytokine stimulation (Supplementary 213 Figure 9C ). The non-responding cells in the RNA-seq experiment likely correspond to these 214 non-responding cells from the flow cytometry experiment, and the observed frequencies of 215 these cells in the RNA-seq and flow populations are consistent with each other ( Pr(observing 6 216 or fewer non-responding cells) = 0.16 under binomial sampling). We discuss this heterogeneity 217 in a further section. Importantly, the lists of up-and down-regulated genes can be used to define 218 gene sets for gene set enrichment analysis in order to identify transcriptional changes related to 219
MAIT activation in bulk experiments. 220 221
Gene set enrichment analysis highlights pathways implicated in MAIT cell activation. 222 We used MAST to perform gene set enrichment analysis (GSEA, see methods) in the MAIT 223 data using the blood transcriptional modules of Li et al 19 . The cell-level scores for the top 9 224 enriched modules ( Figure 3A ) continue to show significant heterogeneity in the stimulated cells, 225
particularly for modules related to T-cell signaling, protein folding, proteasome function, and the 226 AP-1 transcription factor network. Enrichment in stimulated cells (green) and non-stimulated 227 cells (pink) is displayed for each module for the discrete and continuous components of the 228 model ( Figure 3B , see Methods), as well as a Z-score combining the discrete and continuous 229 parts. The enrichment in the T-cell signaling module is driven by the increased expression of 230 IFN-ߛ, GZMB, IL2RA, IL2RB, and TNFRSF9, 5 of the 6 genes in the module. Stimulated cells 231 also exhibit increased energy usage, translation and protein synthesis, while down-regulating 232 genes involved in cell cycle growth and arrest (and other cell cycle related modules). The down-233 regulation of cell cycle growth inhibition genes indicates that IL-12/15/18 signals are sufficient to 234 prepare MAIT cells for cell proliferation. Interestingly, we observe down-regulation of mRNA 235 transcripts from genes in the AP-1 transcription factor network. This has been previously 236 described in dendritic cells in response to LPS stimulation 20 and, indeed, we observe this effect 237 in the mDC data set analyzed here (Supplementary Figure 10 ). 238 239
Our GSEA approach is more powerful than existing methods for bulk RNA-seq data 240
(Supplementary Figure 11 ), and we discover significantly enriched modules with clear patterns 241 of stimulation-induced changes that other methods omit (Supplementary Figure 12 ). Two such 242 modules include the "T-cell surface signature" and "chaperonin mediated protein folding, whose 243 component genes show elevated expression in response to stimulation (Supplementary Figure  244 12A-D). These additional discoveries are not solely due to greater permissiveness in MAST. 245 We applied MAST to identify differentially expressed gene sets across random partitions of the 246 non-stimulated cells, to examine its false discovery rate. As expected, MAST did not detect any 247 significant differences, which suggests that it has good type I error control. 248 249
Residual analysis identifies networks of co-expressed genes implicated in MAIT cell 250 activation. Much of the heterogeneity between the non-responding and responding stimulated 251 cells remains even after removal of marginal (gene level) stimulation effects. Since, MAST 252 models the expected expression value for each cell, we can compute residuals adjusted for 253 known sources of variability (See Methods). The residuals can be compared across genes to 254 characterize cellular heterogeneity and correlation. We observe co-expression in the residuals 255 from stimulated cells that is not evident in the non-stimulated group ( Figure 4A,B ). Since the 256 residuals have removed any marginal changes due to stimulation in each gene, the average 257 residual in the two groups is comparable. The co-expression observed, meanwhile, is due to 258 individual cells expressing these genes dependently, where pairs of genes appear together 259 more often than expected under a model of independent expression. 260 261
Two clusters of co-expressed genes stand out in the residuals of the stimulated cells ( Figure 4 MAIT cells ( Figure 4C ). 266 267
Accounting for the CDR reduces the background correlation observed between genes 268
(Supplementary Figure 13) where nearly 25% of pairwise correlations decrease after CDR 269 correction. When the CDR is included in the model, the number of differentially expressed 270 genes with significant correlations across cells (FDR adjusted p-value < 1%) decreases from 73 271 to 61 in the stimulated cells, and from 808 to 15 in non-stimulated cells. This shows that 272 adjusting for CDR is also important for co-expression analyses as it reduces background co-273 expression attributable to cell volume, which otherwise results in dense, un-interpretable gene 274 networks. 275 276 277
MAST on complex experimental designs: temporal expression patterns of mouse 278 dendritic cell maturation 279
Shalek et al 5 analyzed murine bone-marrow derived dendritic cells simulated using three 280 pathogenic components over the course of six hours and estimated the proportion of cells that 281 expressed a gene and the expression level of expressing cells. We compared results from 282 applying our model to those obtained by Shalek et al 5 when analyzing their lipopolysaccharide 283 (LPS) stimulated cells. As with the MAIT analysis, we used MAST adjusting for the CDR. MAST 284 identified a total of 1359 differentially expressed genes (1996 omitting the CDR), and the CDR 285 accounted for 5.2% of the model deviance in the average gene. 286
The most significantly elevated genes at 6h include CCL5, CD40, IL12B, and Interferon-287 inducible (IFIT) gene family members, while down-regulation was observed for EGR1 and 288 EGR2, transcription factors that are known to negatively regulate dendritic cell 289 immunogenicity 21 . 290 291
GSEA of mouse bone marrow-derived dendritic cells 292
We performed GSEA with the Mouse GO modules and three modules Shalek et al 5 identified. 293
The blood transcriptional modules of Li et al 19 are shown in Supplementary Figure 10 . Figure 5  294 shows module scores for significant GSEA modules for the LPS stimulated cells where the 295 heatmap represents Z values (see methods for details). Besides finding signatures consistent 296 with the modules from Shalek et. al. (Figure 5A ), we identify modules that show similar 297 annotation and overlap significantly with the core antiviral and sustained inflammatory 298 signatures, including several modules linked to type 1 interferon response and antiviral 299 signatures ( Figure 5B ). The "cellular response to interferon-beta" signature (n = 22) overlaps 300
with the original core antiviral signature (n = 99) by 13 genes (hypergeometric p = 1.24x10 -23 ). 301
The response and defense response to virus signatures overlap with the core antiviral signature 302 by 17 of 43 and 22 of 74 genes (hypergeometric p=3.64x10 -26 and 4.08x10 -29 , respectively), 303
suggesting the core antiviral signature captures elements of these known signatures. The 304 chemokine (n=16) and cytokine activity (n=51) modules overlap with the sustained inflammatory 305
(n = 95) module by 5 and 12 genes, respectively (hypergeometric p=5.10x10 -9 and 9.53x10 -16 ). 306
Our modeling approach identifies the two "early marcher" cells in the core antiviral module 307
(marked with triangles on Figure 5A ) corresponding to the same cells highlighted in Figure 4b of 308
Shalek et al 5 . Other modules exhibiting significant time-dependent trends include a module of 309 genes involved in the AP-1 transcription factor network that is down-regulated (Supplementary 310 Figure 10 ), a finding which has been previously shown in human monocytes following LPS 311 stimulation 20 . As with the MAITs, GSEA permutation analysis to evaluate type I error rates did 312 not identify any significant modules (data not shown). These results further confirm the original 313 findings and demonstrate the increased sensitivity of our approach. GSEA heatmaps for the 314 other stimulations can be found in Supplementary Figure 14 . 315 316
Residual analysis of mouse bone marrow-derived dendritic cells identifies sets of co-317 expressed genes. 318 We also explored stimulation-driven correlation patterns. Principal component analysis ( Figure  319 6A) of the model residuals demonstrates a clear time trend associated with PC1, as cells 320 increase co-expression of interferon-activated genes. After removing the marginal stimulation 321
and adjusting for the CDR, we observe correlation between chemokines CCL5, TNF receptor 322 CD40, and interferon-inducible (IFIT) genes ( Figure 6B ). A principal finding of the original 323 publication was the identification of a subset of cells that exhibited an early temporal response 324
to LPS stimulation. Recapitulating the original results here, when we examine the PCA of the 325 residuals using the genes in the core antiviral module, we can identify the "early marcher" cells 326 at the 1h time-point (Supplementary Figure 15 ). The co-expression plot for other stimulations 327
can be found in the supplementary material ( Supplementary Figures 16 and 17 ). 328 329
Discussion 330
We have presented MAST, a flexible statistical framework for the analysis of scRNA-seq data. 331
MAST is suitable for supervised analyses about differential expression of genes and gene-332 modules, as well as unsupervised analyses of model residuals, to generate hypotheses 333 regarding co-expression of genes. MAST accounts for the bimodality of single-cell data by 334 jointly modeling rates of expression (discrete) and positive mean expression (continuous) 335 values. Information from the discrete and continuous parts is combined to perform inference 336 about changes in expression levels using gene or gene-set based statistics. Because our 337 approach uses a generalized linear framework, it can be used to jointly estimate nuisance 338 variation from biological and technical sources, as well as biological effects of interest. In 339 particular, we have shown that it is important to control for the proportion of genes detected in 340 each cell, which we refer to as the cellular detection rate (CDR), as this factor can single-341 handedly explain 13% of the variability in the 90% percentile gene. Adjusting for CDR at least 342 partially controls for differences in abundance due to cell size (and other extrinsic biological and 343 technical effects), while omitting it would lead to overestimated effects of the treatment on the 344 system. Using several scRNA-seq datasets, we showed that our approach provides a 345 statistically rigorous improvement to methods proposed by other groups in this context 5 . 346 347
Because our approach is regression-based, it can be used to compute residuals to explore 348 cellular heterogeneity and gene-gene correlations after selected technical and/or biological 349 effects have been removed. In particular, using this approach, we identify MAIT cells that do not 350 have a typical activated expression profile in response to stimulation (Figures 2 and 3) . The 351
proportion of these cells detected in the scRNASeq experiment is consistent with what was 352 detected in the flow cytometry experiment. These cells do not produce IFN-ߛ or GZMB upon to  353  cytokine stimulation and exhibit expression profiles intermediate to non-stimulated and  354 stimulated cells (Supplementary Figure 18C) . The cells exhibit lower levels of IFN-ߛ and GZMB 355 than activated cells (Supplementary Figure 18A ), but also exhibit decreased expression of AP-1 356 component genes Fos and FosB, consistent with other stimulated cells (Supplementary Figure  357 18B Data for the MAIT study were derived from a single donor who provided written informed 431 consent for immune response exploratory analyses. 
Time-series stimulation of mouse bone-marrow derived dendritic cells (mDC) 458
Processed RNA-seq data (transcripts-per-million, TPM) were downloaded from GEO under 459 accession number GSE41265. Alignment, pre-processing and filtering steps have been 460 previously described 5 . Low quality cells were filtered as described in Shalek et al 5 . 461 462
Single Cell RNA Seq Hurdle model 463 We model the log 2 (TPM+1) expression matrix as a two part generalized regression model. The 464 cell expression rate given a design is modeled using logistic regression and the expression level 465 is modeled as conditionally Gaussian given that they are expressed. 466 467
Given normalized, possibly thresholded (see supplementary material), scRNA-seq expression 468 
The regression coefficients of the discrete component are regularized using a Bayesian 476 approach as implemented in the bayesglm function of the arm R package, which uses weakly 477
informative priors 27 to provide sensible estimates under linear separation (See supplementary 478 material for details). We also perform regularization of the continuous model variance 479 parameter, as described below, which helps increases robustness of gene-level differential 480 expression analysis when a gene is only expressed in a few cells. 481 482 We define the cellular detection rate (CDR) as the proportion of genes detected in each cell. 483
The CDR for cell ݅ is: 484
An advantage of our approach is that it is straightforward to account for CDR variability by 485 adding the variable as a covariate in the discrete and continuous models (column of the design 486 matrix, ܺ , defined above Testing for enriched Gene Ontology terms based on list of genes was performed with the 545
GOrilla online tool using the approach of comparing an unranked target list against a 546 background list 33 . 547 548
Residual Analysis 549
The hurdle model, in general, provides two residuals: one for the discrete component and one 550
for the continuous component. Standardized deviance residuals are calculated for the discrete 551 and continuous component separately, and then we combine the residuals by averaging them. 552
If a cell is unexpressed, then its residual is missing and it is omitted from the average. See the 553 supplement for details. 554 555
Module Scores 556
In order to assess the degree to which each cell exhibits enrichment for each gene module, we 557 use quantities available through our model to define module "scores", which are defined as the 558 observed expression corrected for CDR effect, analogous to those defined by Shalek et al 5 and contributed manuscript preparation and feedback and data interpretation. AKS contributed 574
the mDC data and contributed manuscript feedback and to data interpretation. JD contributed to 575 data analysis of the single-cell expression data. MJM contributed samples and to study design. 576 577
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